Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

“A world without patients”: this is the motto of the Arizona State University spin-off company manufacturing microchips for research on “Immunosignatures”. By its developers, immunosignatures (ImSg) are presented as a “technological revolution” able to transform diagnostics and improve the American healthcare system. How is the plausibility of these expectations constructed and how can it be assessed? Chapters 3, 4 and 5 of this book use the Nanopil to justify and explain the single steps of a framework for analyzing the plausibility of expectations of emerging technologies. This chapter illustrates the wider applicability of this framework using the case of ImSg. After an introduction on the promise of this technology and a description of the research design, the two central sections analyze expectations in relation to this technoscientific project and its context of use. Based on these analyses, the plausibility of expectations that the ImSg will bring about desirable outcomes is discussed. The chapter concludes with a reflection on the plausibility assessment framework through a comparison of the cases of the Nanopil and Immunosignature.

Original publication

DOI

10.1007/978-3-319-23282-9_6

Type

Chapter

Book title

International Library of Ethics, Law and Technology

Publication Date

01/01/2016

Volume

15

Pages

125 - 154